Cargando…

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors

Malignant melanoma is the most aggressive type of skin cancer and is closely associated with the development of brain metastases. Despite aggressive treatment, the prognosis has traditionally been poor, necessitating improved therapies. In melanoma, the mitogen activated protein kinase and the phosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nymark Aasen, Synnøve, Parajuli, Himalaya, Hoang, Tuyen, Feng, Zichao, Stokke, Krister, Wang, Jiwei, Roy, Kislay, Bjerkvig, Rolf, Knappskog, Stian, Thorsen, Frits
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747502/ https://www.ncbi.nlm.nih.gov/pubmed/31470659 http://dx.doi.org/10.3390/ijms20174235

Ejemplares similares

Cabozantinib Is Effective in Melanoma Brain Metastasis Cell Lines and Affects Key Signaling Pathways
por: Mannsåker, Trond Are, et al.
Publicado: (2021)

BSCI-12. Inhibition of melanoma brain metastasis by targeting miR-146a
por: Wang, Jiwei, et al.
Publicado: (2021)

Current landscape and future perspectives in preclinical MR and PET imaging of brain metastasis
por: Aasen, Synnøve Nymark, et al.
Publicado: (2021)

CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells
por: Reigstad, Agathe, et al.
Publicado: (2022)

In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways
por: Daphu, Inderjit, et al.
Publicado: (2014)

A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines
por: Aasen, Synnøve Nymark, et al.
Publicado: (2015)

Inhibition of extracellular vesicle‐derived miR‐146a‐5p decreases progression of melanoma brain metastasis via Notch pathway dysregulation in astrocytes
por: Rigg, Emma, et al.
Publicado: (2023)

THER-11. PEPTIDE-MEDIATED PERMEABILIZATION OF THE BLOOD-BRAIN BARRIER IMPROVES DRUG DELIVERY TO BRAIN METASTASIS
por: Aasen, Synnøve Nymark, et al.
Publicado: (2019)

Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis
por: Sundstrøm, Terje, et al.
Publicado: (2019)

Matrine induces senescence of human glioblastoma cells through suppression of the IGF1/PI3K/AKT/p27 signaling pathway
por: Zhou, Wenjing, et al.
Publicado: (2018)

Reduced expression of proteolipid protein 2 increases ER stress‐induced apoptosis and autophagy in glioblastoma
por: Feng, Zichao, et al.
Publicado: (2019)

Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines
por: Yndestad, Synnøve, et al.
Publicado: (2017)

High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function
por: Yndestad, Synnøve, et al.
Publicado: (2017)

Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma
por: Pedini, Francesca, et al.
Publicado: (2019)

Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
por: Birkeland, Einar, et al.
Publicado: (2013)

In vivo models of primary brain tumors: pitfalls and perspectives
por: Huszthy, Peter C., et al.
Publicado: (2012)

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
por: Pappalardo, Francesco, et al.
Publicado: (2016)

Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
por: Deken, Marcel A., et al.
Publicado: (2016)

Cover Image
por: Zhou, Wenjing, et al.
Publicado: (2018)

MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk
por: Knappskog, Stian, et al.
Publicado: (2011)

Chemosensitivity and p53; new tricks by an old dog
por: Lønning, Per E, et al.
Publicado: (2012)

BRCA1 methylation in newborns: genetic disposition, maternal transfer, environmental influence, or by chance only?
por: Lønning, Per Eystein, et al.
Publicado: (2018)

Alterations of the retinoblastoma gene in metastatic breast cancer
por: Berge, Elisabet Ognedal, et al.
Publicado: (2011)

Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination
por: Zhang, Xin, et al.
Publicado: (2017)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens
por: Løes, Inger Marie, et al.
Publicado: (2014)

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab
por: Forthun, Rakel Brendsdal, et al.
Publicado: (2019)

Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines
por: Huun, Johanna, et al.
Publicado: (2017)

ramr: an R/Bioconductor package for detection of rare aberrantly methylated regions
por: Nikolaienko, Oleksii, et al.
Publicado: (2021)

epialleleR: an R/Bioconductor package for sensitive allele-specific methylation analysis in NGS data
por: Nikolaienko, Oleksii, et al.
Publicado: (2023)

The MAPK pathway as an apoptosis enhancer in melanoma
por: Haydn, Johannes M., et al.
Publicado: (2014)

Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition
por: Guardamagna, Mora, et al.
Publicado: (2022)

Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
por: Han, Mingzhi, et al.
Publicado: (2020)

Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
por: Han, Mingzhi, et al.
Publicado: (2019)

PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
por: Corrales, Eyleen, et al.
Publicado: (2022)

Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway
por: Alver, Tine Norman, et al.
Publicado: (2022)

Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers
por: Bjørnslett, Merete, et al.
Publicado: (2012)

TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy
por: Eikesdal, Hans P., et al.
Publicado: (2014)

Adjuvant treatment: the contribution of expression microarrays
por: Lønning, Per Eystein, et al.
Publicado: (2007)

Constitutional Mosaic Epimutations - a hidden cause of cancer?
por: Lønning, Per E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ea2annvdfe53c98i10ahu2b8qb